<SEC-DOCUMENT>0000950170-25-059375-index.html : 20250428
<SEC-HEADER>0000950170-25-059375.hdr.sgml : 20250428
<ACCEPTANCE-DATETIME>20250428164641
ACCESSION NUMBER:		0000950170-25-059375
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250428
DATE AS OF CHANGE:		20250428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lexeo Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001907108
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				854012572
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41855
		FILM NUMBER:		25881207

	BUSINESS ADDRESS:	
		STREET 1:		345 PARK AVENUE SOUTH
		STREET 2:		FLOOR 6
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010
		BUSINESS PHONE:		(212) 547-9879

	MAIL ADDRESS:	
		STREET 1:		345 PARK AVENUE SOUTH
		STREET 2:		FLOOR 6
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>lxeo-def_14a-2025_proxy.htm
<DESCRIPTION>DEF 14A
<TEXT>
Document 1 - file: lxeo-def_14a-2025_proxy.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>img209845168_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: img209845168_0.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img209845168_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: img209845168_1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img209845168_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: img209845168_2.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img209845168_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: img209845168_3.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>img209845168_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: img209845168_4.jpg

</DOCUMENT>
</SEC-DOCUMENT>